Drug information

Download files:
Brand Name
Other Names
BIC / FTC / TAF, bictegravir sodium / emtricitabine / tenofovir alafenamide fumarate
Drug Class
Combination Drugs
Integrase Strand Transfer Inhibitor (bictegravir)
Nucleoside Reverse Transcriptase Inhibitor (emtricitabine, tenofovir alafenamide)
Drug Image(s): (Click to enlarge)
Chemical Image: (Click to enlarge)

Bictegravir sodium

Molecular Weight: 471.3653


Molecular Weight: 247.249

Tenofovir alafenamide fumarate

Molecular Weight: 1069.0138

(The drug image[s] shown above are of brand products only. There may be other available products not shown.)

FDA label informationFDA label information

Several FDA-approved drug labels may be available for bictegravir / emtricitabine / tenofovir alafenamide. Clinicalinfo provides the following link to the DailyMed drug label solely as an example of the labels available for bictegravir / emtricitabine / tenofovir alafenamide. Inclusion or absence of a drug label link on the Clinicalinfo site does not imply endorsement or lack thereof by Clinicalinfo. Search DailyMed or Drugs@FDA to access more information on bictegravir / emtricitabine / tenofovir alafenamide, including additional drug labels and any generic equivalents.